PubRank

M J Boyer

Author PubWeight™ 29.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The dynamics of change: cancer patients' preferences for information, involvement and support. Ann Oncol 1997 3.50
2 Communication styles in the cancer consultation: preferences for a patient-centred approach. Psychooncology 2000 2.59
3 Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking. Br J Cancer 1999 1.63
4 Association of lipids with integral membrane surface proteins of Mycoplasma hyorhinis. Infect Immun 1988 1.58
5 Triton X-114 phase fractionation of an integral membrane surface protein mediating monoclonal antibody killing of Mycoplasma hyorhinis. Infect Immun 1987 1.55
6 Evaluation of the role of positron emission tomography in oncology. Med J Aust 2000 1.38
7 Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol 2003 1.38
8 Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol 1997 1.12
9 Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Arch Intern Med 1993 1.05
10 Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial. Australian and New Zealand Germ Cell Trial Group. Lancet 2001 1.03
11 Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer. Ann Oncol 2002 1.00
12 The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer 1998 0.98
13 Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust 1991 0.95
14 Involvement of Shc and Cbl-PI 3-kinase in Lyn-dependent proliferative signaling pathways for G-CSF. Oncogene 2000 0.95
15 Disarming the guarded prognosis: predicting survival in newly referred patients with incurable cancer. Br J Cancer 2006 0.90
16 Management of malignant pleural effusions. Thorax 1990 0.84
17 A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group. Cancer Chemother Pharmacol 2010 0.82
18 Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer. J Clin Pathol 2013 0.80
19 Weekly docetaxel as second line treatment after mitozantrone for androgen-independent prostate cancer. Intern Med J 2005 0.79
20 Smoking reduction does work: resulting alterations in the incidence and histological subtypes of lung cancer in New South Wales in the last 20 years. Respirology 2005 0.78
21 [Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay]. Ann Biol Clin (Paris) 1999 0.78
22 Resection of residual pulmonary masses after chemotherapy in patients with metastatic non-seminomatous germ cell tumours. Intern Med J 2002 0.77
23 mu-Opioid receptors and not kappa-opioid receptors are coupled to the adenylate cyclase in the cerebellum. J Neurochem 1990 0.77
24 [Glutathione peroxidases: value of their determination in clinical biology]. Ann Biol Clin (Paris) 1997 0.76
25 [Production of oxygen free radicals in myocardial infarction treated by thrombolysis. Analysis of glutathione peroxidase, superoxide dismutase and malondialdehyde]. Arch Mal Coeur Vaiss 1994 0.75
26 Testicular cancer management. Med J Aust 2001 0.75
27 Partnership for change: improving the medication experience. NLN Publ 1993 0.75
28 The use of Histolyn CYL in an enzyme immunoassay to detect Histoplasma capsulatum antibodies. Sabouraudia 1983 0.75
29 Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer. Intern Med J 2013 0.75
30 Coupling of mu-opioid receptors with adenylate cyclase in naive and morphine tolerant rabbits. Prog Clin Biol Res 1990 0.75
31 Plasma phospholipid fatty acids and urinary excretion of prostaglandins PGE1 and PGE2 in infants during total parenteral nutrition, with continuous or sequential administration of fat emulsion. JPEN J Parenter Enteral Nutr 1987 0.75
32 Non-surgical therapy for patients with advanced non-small cell lung cancer. Respirology 1998 0.75
33 [Screening of essential fatty acid deficiency in children. Respective value of the assay of fatty acids in total lipids and lipid fractions of the serum]. Ann Biol Clin (Paris) 1986 0.75
34 Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer. Med J Aust 1997 0.75
35 Leadership and collaboration: sharing of power. NLN Publ 1995 0.75
36 Prolonged survival after the diagnosis of metastatic hepatic epitheliod haemangioendothelioma. Intern Med J 2004 0.75